An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease

Sandra V. Kik, Samuel Schumacher, Daniela Maria Cirillo, Gavin Churchyard, Catharina Boehme, Delia Goletti, Molebogeng X. Rangaka, Claudia M. Denkinger, Christian Lienhardt, Christopher Gilpin, Alberto Matteelli, Frank Cobelens

Source: Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018
Journal Issue: October
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sandra V. Kik, Samuel Schumacher, Daniela Maria Cirillo, Gavin Churchyard, Catharina Boehme, Delia Goletti, Molebogeng X. Rangaka, Claudia M. Denkinger, Christian Lienhardt, Christopher Gilpin, Alberto Matteelli, Frank Cobelens. An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. Eur Respir J, 52 (4) 1800946; 10.1183/13993003.00946-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Framework for the evaluation of new tests for tuberculosis infection
Source: Eur Respir J, 58 (2) 2004078; 10.1183/13993003.04078-2020
Year: 2021



Sputum induction for assessment of biomarkers in early development of new drugs for respiratory disease in a proof of concept setting
Source: International Congress 2016 – Airway biomarkers
Year: 2016


PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012


Evaluation of new biomarkers for laboratory diagnosis of tuberculosis
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Transcriptional biomarkers for predicting development of tuberculosis: progress and clinical considerations
Source: Eur Respir J, 55 (3) 1901957; 10.1183/13993003.01957-2019
Year: 2020



T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation
Source: Eur Respir J, 51 (3) 1800153; 10.1183/13993003.00153-2018
Year: 2018



How to better assess and predict disease progression and treatment response: home-based spirometry, biomarkers or …?
Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?
Year: 2019


The set of immunological tests for detection of active tuberculosis in children with latent infection
Source: International Congress 2019 – Paediatric tuberculosis
Year: 2019

Antibody and host inflammatory biomarker combinations as diagnostic tools for TB disease
Source: International Congress 2017 – Update on TB: latest news
Year: 2017



The definition of tuberculosis infection based on the spectrum of tuberculosis disease
Source: Breathe, 17 (3) 1900655; 10.1183/20734735.0079-2021
Year: 2021



Advancing global programmatic management of latent tuberculosis infection for at risk populations
Source: Eur Respir J 2016; 47:1327-1330
Year: 2016


The influence of SARS-CoV-2 co-infection and active tuberculosis on the severity of the disease course and mortality.
Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Year: 2021


A basic prediction model with clinical parameters to diagnose lung cancer.
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021


Correlates of tuberculosis risk: predictive biomarkers for progression to active tuberculosis
Source: Eur Respir J 2016; 48: 1751-1763
Year: 2016



A new paradigm for classification of disease severity and progression of COPD
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012

Does radiological lesions extent predict pulmonary tuberculosis outcome?
Source: Annual Congress 2009 - Clinical tuberculosis
Year: 2009


Are in vitro sensitivity tests for tuberculosis drugs a good guide of clinical outcome?
Source: Annual Congress 2006 - The management of multidrug-resistant tuberculosis (MDRTB) on an individual and national level
Year: 2006

Results of retrospective-prospective comparison study of different immunologic tests in diagnosis of tuberculosis infection
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018



The value of immunological methods in the complex diagnostics of TB in chronic renal failure patients in the terminal stage
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019